======= ZBTB2 ======= == Gene Information == * **Official Symbol**: ZBTB2 * **Official Name**: zinc finger and BTB domain containing 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57621|57621]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N680|Q8N680]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZBTB2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZBTB2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616595|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May be involved in transcriptional regulation. |BTB| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |RNA polymerase II proximal promoter sequence-specific DNA binding| |negative regulation of transcription by RNA polymerase II| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp124|GSK343 3μM R03 exp124]]|-2.95| |[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|-1.75| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|-1.7| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|1.73| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.8| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|1.8| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|1.93| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|1.99| |[[:results:exp180|Dynasore 10μM R04 exp180]]|2| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|2.25| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|2.48| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|2.77| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2403 * **Expression level (log2 read counts)**: 5.09 {{:chemogenomics:nalm6 dist.png?nolink |}}